查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1607168

基因克隆服務市場：按服務、應用程式和最終用戶分類 - 2025-2030 年全球預測

Gene Cloning Services Market by Service (Custom Cloning Service, Gene Synthesis Service, Molecular Biology Service), Application (Gene Expression, Gene Synthesis, Gene Therapy), End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

基因克隆服務市場2023年估值為23.8億美元，預計到2024年將達到26.3億美元，複合年成長率為11.96%，到2030年預計將達到52.5億美元。

基因克隆服務涵蓋生物技術和醫學研究所必需的廣泛技術和應用，旨在複製遺傳物質以促進各個領域的研究。對基因克隆的需求，以複製特定基因的能力為突出，使得藥物開發、農業、基因治療和個人化醫療取得了重要進展。其應用涵蓋各領域，包括製藥、基因改造作物農業以及基因研究學術。生物技術公司、研究機構和臨床實驗室等最終用途產業正在利用基因克隆來創新和改進產品和治療方法。

主要市場統計
基準年[2023] 23.8億美元
預計年份 [2024] 26.3億美元
預測年份 [2030] 52.5億美元
複合年成長率（%） 11.96%

推動市場成長的主要因素包括生物製藥需求的成長、克隆技術的技術進步以及基因研究投資的增加。最近的趨勢包括CRISPR-Cas9技術，它提高了基因編輯的準確性和效率，並引起人們的關注，創造了巨大的市場機會。鼓勵公司投資開發更具成本效益的克隆技術，並探索合資企業以擴大其服務組合和覆蓋範圍。

然而，市場面臨基因操縱的倫理擔憂、嚴格的法律規範和高昂的營運成本等挑戰。這些限制可能會阻礙服務的順利擴展。透過強力的道德準則和監管合規性，消除公眾的看法並提高基因研究的透明度，可以緩解這些挑戰。

在創新方面，生物技術公司可能會專注於提高克隆效率，透過自動化和可擴展性降低成本，以及整合人工智慧來預測克隆結果。探索基於植物的克隆和微生物系統等利基市場可能會開闢新的途徑。基因克隆市場的本質是動態和競爭的，受到快速技術進步和對創新解決方案的迫切需求的推動。透過利用新的科學研究，企業可以處於這一不斷發展的格局的最前沿，確保永續成長並為科學進步做出重大貢獻。

市場動態：揭示快速發展的基因克隆服務市場的關鍵市場洞察

供需的動態交互作用正在改變基因克隆服務市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 生物醫學和生物技術研究的增加
    • 越來越重視基因治療和個人化醫療
    • 藥物發現和藥物開發活動的增加
  • 市場限制因素
    • 與基因克隆服務相關的高成本
  • 市場機會
    • 基因工程技術不斷進步
    • 擴大基因克隆在農業的應用
  • 市場挑戰
    • 道德問題和熟練專業人員的短缺

波特五力：駕馭基因複製服務市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解基因克隆服務市場的外部影響

外部宏觀環境因素在塑造基因克隆服務市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解基因克隆服務市場的競爭狀況

基因克隆服務市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣基因克隆服務市場廠商績效評估

FPNV 定位矩陣是評估基因克隆服務市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，以確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製基因克隆服務市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，基因克隆服務市場的策略分析至關重要。透過考慮關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 生物醫學和生物技術研究的進展
      • 越來越重視基因治療和個人化醫療
      • 增加藥物發現和開發活動
    • 抑制因素
      • 與基因克隆服務相關的高成本
    • 機會
      • 基因工程技術不斷進步
      • 擴大基因克隆在農業的應用
    • 任務
      • 道德問題和缺乏熟練的專業人員
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 基因克隆服務市場：依服務分類

  • 自訂克隆服務
  • 基因合成服務
  • 分子生物學服務

第7章 基因克隆服務市場：依應用分類

  • 基因表現
  • 基因合成
  • 基因治療
  • 疫苗調查

第8章 基因克隆服務市場：依最終用戶分類

  • 學術/研究機構
  • 臨床實驗室
  • 製藥和生物技術公司

第9章 北美和南美基因克隆服務市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太基因克隆服務市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲基因克隆服務市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Amid Biosciences
  • Aragen Life Sciences Technologies
  • Azenta US, Inc.
  • Bio-Techne Corporation
  • Canvax Reagents SL
  • Cellecta, Inc.
  • Charles River Laboratories International, Inc.
  • Creative Biogene
  • Curia
  • Eurofins Scientific SE
  • GenScript
  • Integrated DNA Technologies, Inc.
  • Lonza Group AG
  • Macrogen, Inc.
  • MedGenome Inc.
  • Merck KGaA
  • Sartorius AG
  • Sino Biological, Inc.
  • Synbio Technologies
  • Syngene International Limited
  • Takara Bio Inc.
  • Telesis Bio Inc.
  • Thermo Fisher Scientific Inc.
  • TransGen Biotech Co., Ltd
  • Twist Bioscience Corporation
Product Code: MRR-2E76C3E47FBD

The Gene Cloning Services Market was valued at USD 2.38 billion in 2023, expected to reach USD 2.63 billion in 2024, and is projected to grow at a CAGR of 11.96%, to USD 5.25 billion by 2030.

Gene cloning services encompass a broad range of techniques and applications vital to biotechnology and medical research, aimed at reproducing genetic materials to facilitate studies in various domains. The necessity of gene cloning is underscored by its ability to replicate specific genes, enabling crucial advancements in drug development, agriculture, gene therapy, and personalized medicine. Applications span across sectors, including pharmaceuticals, agriculture for GMOs, and academia for genetic research. End-use industries such as biotechnology companies, research institutes, and clinical laboratories leverage gene cloning to innovate and refine products and therapies.

KEY MARKET STATISTICS
Base Year [2023] USD 2.38 billion
Estimated Year [2024] USD 2.63 billion
Forecast Year [2030] USD 5.25 billion
CAGR (%) 11.96%

Key factors driving market growth include the rising demand for biopharmaceuticals, technological advancements in cloning techniques, and increased investment in genetic research. Recent developments must be noted, such as CRISPR-Cas9 technology, enhancing precision and efficiency in gene editing, representing significant market opportunities. Companies are recommended to invest in developing more cost-effective cloning technologies and explore collaborative ventures to expand their service portfolios and reach.

However, the market faces challenges such as ethical concerns over genetic manipulation, stringent regulatory frameworks, and high operational costs. These limitations could hinder the smooth expansion of services. Addressing public perception and fostering transparency in genetic research through robust ethical guidelines and regulatory compliance can mitigate these challenges.

For innovation, biotech firms might focus on enhancing cloning efficiency, reducing costs through automation and scalability, and integrating AI to predict cloning outcomes. Research into niche markets like plant-based cloning and microbial systems could open new avenues. The nature of the gene cloning market is dynamic and competitive, driven by rapid technological advances and a pressing need for innovative solutions. By tapping into emerging scientific research, firms can position themselves at the forefront of this evolving landscape, ensuring sustainable growth and significant contributions to scientific advancements.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Cloning Services Market

The Gene Cloning Services Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in biomedical and biotechnological research
    • Growing emphasis on gene therapies and personalized medicine
    • Increase in drug discovery and development activities
  • Market Restraints
    • High cost associated with gene cloning services
  • Market Opportunities
    • Ongoing advancements in genetic engineering techniques
    • Expanding applications of gene cloning in agriculture
  • Market Challenges
    • Ethical concerns and shortage of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Gene Cloning Services Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Cloning Services Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Cloning Services Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Cloning Services Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Cloning Services Market

A detailed market share analysis in the Gene Cloning Services Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Cloning Services Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Cloning Services Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gene Cloning Services Market

A strategic analysis of the Gene Cloning Services Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gene Cloning Services Market, highlighting leading vendors and their innovative profiles. These include Amid Biosciences, Aragen Life Sciences Technologies, Azenta US, Inc., Bio-Techne Corporation, Canvax Reagents SL, Cellecta, Inc., Charles River Laboratories International, Inc., Creative Biogene, Curia, Eurofins Scientific SE, GenScript, Integrated DNA Technologies, Inc., Lonza Group AG, Macrogen, Inc., MedGenome Inc., Merck KGaA, Sartorius AG, Sino Biological, Inc., Synbio Technologies, Syngene International Limited, Takara Bio Inc., Telesis Bio Inc., Thermo Fisher Scientific Inc., TransGen Biotech Co., Ltd, and Twist Bioscience Corporation.

Market Segmentation & Coverage

This research report categorizes the Gene Cloning Services Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Service, market is studied across Custom Cloning Service, Gene Synthesis Service, and Molecular Biology Service.
  • Based on Application, market is studied across Gene Expression, Gene Synthesis, Gene Therapy, and Vaccine Research.
  • Based on End User, market is studied across Academic & Research Institutions, Clinical Laboratories, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in biomedical and biotechnological research
      • 5.1.1.2. Growing emphasis on gene therapies and personalized medicine
      • 5.1.1.3. Increase in drug discovery and development activities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with gene cloning services
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing advancements in genetic engineering techniques
      • 5.1.3.2. Expanding applications of gene cloning in agriculture
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical concerns and shortage of skilled professionals
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Gene Cloning Services Market, by Service

  • 6.1. Introduction
  • 6.2. Custom Cloning Service
  • 6.3. Gene Synthesis Service
  • 6.4. Molecular Biology Service

7. Gene Cloning Services Market, by Application

  • 7.1. Introduction
  • 7.2. Gene Expression
  • 7.3. Gene Synthesis
  • 7.4. Gene Therapy
  • 7.5. Vaccine Research

8. Gene Cloning Services Market, by End User

  • 8.1. Introduction
  • 8.2. Academic & Research Institutions
  • 8.3. Clinical Laboratories
  • 8.4. Pharmaceutical & Biotechnology Companies

9. Americas Gene Cloning Services Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Gene Cloning Services Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Gene Cloning Services Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amid Biosciences
  • 2. Aragen Life Sciences Technologies
  • 3. Azenta US, Inc.
  • 4. Bio-Techne Corporation
  • 5. Canvax Reagents SL
  • 6. Cellecta, Inc.
  • 7. Charles River Laboratories International, Inc.
  • 8. Creative Biogene
  • 9. Curia
  • 10. Eurofins Scientific SE
  • 11. GenScript
  • 12. Integrated DNA Technologies, Inc.
  • 13. Lonza Group AG
  • 14. Macrogen, Inc.
  • 15. MedGenome Inc.
  • 16. Merck KGaA
  • 17. Sartorius AG
  • 18. Sino Biological, Inc.
  • 19. Synbio Technologies
  • 20. Syngene International Limited
  • 21. Takara Bio Inc.
  • 22. Telesis Bio Inc.
  • 23. Thermo Fisher Scientific Inc.
  • 24. TransGen Biotech Co., Ltd
  • 25. Twist Bioscience Corporation

LIST OF FIGURES

  • FIGURE 1. GENE CLONING SERVICES MARKET RESEARCH PROCESS
  • FIGURE 2. GENE CLONING SERVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL GENE CLONING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. GENE CLONING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. GENE CLONING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. GENE CLONING SERVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL GENE CLONING SERVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GENE CLONING SERVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY CUSTOM CLONING SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY MOLECULAR BIOLOGY SERVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GENE EXPRESSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GENE SYNTHESIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY VACCINE RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GENE CLONING SERVICES MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES GENE CLONING SERVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA GENE CLONING SERVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY SERVICE, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM GENE CLONING SERVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. GENE CLONING SERVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 148. GENE CLONING SERVICES MARKET, FPNV POSITIONING MATRIX, 2023